Group 1 - Yitong Century won a bid for a communication engineering construction service project from China Mobile, with a total bid amount of 228 million yuan (including tax) [1] - Zhiyuan New Energy plans to repurchase shares worth between 33 million and 66 million yuan, with a maximum repurchase price of 22.00 yuan per share [1] - GAC Group reported April automobile sales of 116,400 units, a year-on-year decrease of 12.66% [2] - JAC Motors reported April automobile sales of 30,764 units, a year-on-year decrease of 3.55% [3] Group 2 - Fosun Pharma's subsidiary received FDA approval for a clinical trial of a live biotherapeutic product aimed at treating androgenetic alopecia [4] - Liangxin Co. obtained multiple patent certificates, including 2 invention patents and 32 utility model patents [5] - Sainuo Medical's two products received medical device registration certificates in Mexico and Ecuador [5] - Huayu Pharmaceutical's two products received marketing approvals in France and Spain [6] Group 3 - Shengnong Development reported April sales revenue of 1.533 billion yuan, a year-on-year increase of 0.68% [6] - Hasi Lian's potassium chloride and sodium chloride injection passed the consistency evaluation [7] - Shapuaisi received approval for a supplemental application for levofloxacin eye drops [9] - Tianyu Biological reported April sales revenue of 59.32 million yuan from pig sales [10] Group 4 - *ST Weihai was pre-awarded a project worth 108 million yuan [12] - Luoniushan reported April sales revenue of 125 million yuan from pig sales, a year-on-year increase of 12.72% [13] - Minhe Co. reported April sales revenue of 68.30 million yuan from chick sales, a year-on-year increase of 0.51% [14] Group 5 - Double Ring Technology's application for a specific stock issuance was approved by the Shenzhen Stock Exchange [15] - Hualu Hengsheng plans to repurchase shares worth between 200 million and 300 million yuan [16] - Baolong Technology plans to repurchase shares worth between 100 million and 200 million yuan [17] Group 6 - Huasheng Technology's subsidiary plans to sell shares of a company for 200 million yuan [24] - *ST Gengxing's controlling shareholder plans to increase holdings worth between 30 million and 60 million yuan [25] - Ruihuatai's shareholder plans to reduce holdings by up to 1% of the company's shares [26] Group 7 - Foton Motor reported April commercial vehicle sales of 54,816 units, a year-on-year increase of 21.63% [20] - China Merchants Bank plans to invest 15 billion yuan to establish a financial asset investment company [22] - Jinchengxin plans to invest approximately 231 million USD in the Alacran copper-gold-silver mine project [23] Group 8 - Zhongji United's controlling shareholder plans to reduce holdings by up to 2% of the company's shares [30] - Ningbo Huaxiang signed a strategic cooperation agreement to strengthen collaboration in various areas [31] - SMIC reported a net profit of 1.356 billion yuan for Q1 2025, a year-on-year increase of 166.5% [32] Group 9 - FAW Fuwi received a project notification to develop seat products for a luxury brand, with a total sales amount expected to be 1.39 billion yuan [33] - Huakang Clean won a bid for a purification project worth 64.425 million yuan [34] - Lihua Co. reported April sales revenue of 1.125 billion yuan from chicken sales [35]

Core Viewpoint - SMIC reported significant growth in revenue and net profit for Q1 2025, driven by increased wafer sales and a shift in high-end process product mix [1] Financial Performance - Revenue for Q1 2025 reached 16.301 billion yuan, a year-on-year increase of 29.4% [1] - Net profit attributable to shareholders was 1.356 billion yuan, up 166.5% year-on-year [1] - Wafer sales volume was 2.2922 million pieces, compared to 1.7949 million pieces in the same period last year, marking a 27.7% increase [1] - Monthly production capacity at the end of the quarter was 973,300 pieces, up from 814,500 pieces year-on-year [1] - Capacity utilization rate for the quarter was 89.6%, compared to 80.8% in the same period last year [1] Challenges and Outlook - The average selling price declined in the latter half of Q1 due to unexpected issues in production lines and the need for performance improvements in new equipment, impacting revenue expectations [1] - SMIC anticipates a revenue decline of 4% to 6% in Q2, with gross margin expected to be between 18% and 20% [1] - The company aims to enhance its adaptability and risk resistance while focusing on its core operations in the second half of the year [1] Shareholder Activity - Significant reduction in shareholding by Xin Xin (Hong Kong) Investment Co., Ltd., which decreased its holdings from 7.74% to 6.91% by selling approximately 65.9772 million H-shares [2] - This marks the first reduction in holdings by the National Integrated Circuit Industry Investment Fund (commonly known as "Big Fund") since Q2 2021 [2] - The Big Fund has been in a capital recovery phase since its establishment in 2014, and this reduction is seen as a normal operation to reinvest in more promising semiconductor sectors or emerging enterprises [2]

Financial Data and Key Metrics Changes - Revenue for Q1 2025 was $247 million, representing a sequential increase of 1.8% [4] - Gross margin was 22.5%, down 0.1 percentage points sequentially [4] - Profit from operations was $310 million, and EBITDA was $1.292 billion with an EBITDA margin of 57.5% [4] - Total assets at the end of Q1 were $48 billion, with total cash on hand of $12.7 billion [5] - Total liabilities were $15.7 billion, with total debt at $11.3 billion [5] - The debt to equity ratio was 34.9%, and the net debt to equity ratio was negative 4.5% [5] - Net cash used in operating activities was $160 million, while net cash used in investing activities was $1.328 billion [5] Business Line Data and Key Metrics Changes - Revenue from wafer sales accounted for 95.2% of total revenue, with wafer revenue increasing by close to 5% sequentially [9] - Revenue from 8-inch and 12-inch wafers increased by 182% sequentially, driven by customer shipment pull-in due to geopolitical changes and demand rise in commodity products [10] - Revenue from industrial and automotive sectors increased by more than 20% sequentially, contributing to an increase in overall shipments by 15% [11] - Revenue from automotive products increased from 8% to 10% of total revenue, benefiting from major customers' achievements in the automotive field [12] Market Data and Key Metrics Changes - Revenue distribution by region: China accounted for 84%, the Americas 13%, and EUAsia 3% [11] - Revenue from overseas markets increased sequentially, primarily due to geopolitical factors and demand shifts [11] - The company observed a strong demand from BCD, MCU, and specialty memory platforms, with overall revenue from these platforms increasing around 20% sequentially [13] Company Strategy and Development Direction - The company is focusing on capacity expansion and R&D activities to enhance core competitiveness and corporate value [6][7] - The company plans not to distribute profits for 2024 to align with long-term development needs and shareholder interests [7] - The company aims to maintain its leading position in a competitive market through strategic investments [7] Management's Comments on Operating Environment and Future Outlook - The company expects a revenue decrease of 4% to 6% sequentially in Q2 2025, with gross margin guidance between 18% to 20% [15] - Management noted that while there are new market factors, the fundamentals remain largely unchanged compared to Q1 [16] - The company is enhancing its adaptability and risk resilience capabilities in response to market challenges [19] - There is uncertainty regarding the second half of the year, particularly concerning tariff policies and demand fluctuations [18] Other Important Information - The company is in a critical phase of capacity construction and market share expansion, requiring continuous capital expenditures [6] - The capacity utilization rate increased by 4.1 percentage points sequentially to 89.6% [14] Q&A Session Summary Question: What are the expectations for revenue in the second quarter? - The company expects a revenue decrease of 4% to 6% sequentially, with stable shipment units but a decrease in blended ASP [15] Question: How is the company addressing the challenges in the current market? - The company is focusing on cost reduction and efficiency improvements to mitigate the impact of price fluctuations [15]

Core Insights - The establishment of a cross-provincial and cross-customs area air freight station in Suzhou is addressing long-standing logistics pain points for high-value goods in the biopharmaceutical, integrated circuit, and high-end equipment manufacturing sectors [1][2][3] - The new air freight service has improved logistics efficiency by 12 to 24 hours and reduced ground logistics costs by 10% to 30% for exporting companies [1][2] - The initiative reflects a broader trend of regional collaboration and innovation in the Yangtze River Delta, enhancing the logistics ecosystem and facilitating faster global access for Suzhou enterprises [1][4][10] Logistics Challenges - Suzhou's geographical limitations have historically posed a "last mile" logistics bottleneck for export companies, particularly those relying heavily on air transport [2][3] - Traditional logistics processes involved multiple steps and significant delays, often taking two to three days for customs checks and airport security [2][3] Government and Institutional Response - The construction of the air freight station was prioritized by local government authorities, driven by the need to enhance logistics efficiency for high-value exports [3][4] - Collaborative efforts among various government departments and agencies have led to the successful implementation of the air freight station, breaking down barriers between regions and departments [4][6] Technological Innovations - The air freight station features a smart regulatory system that allows customs checks to be completed in Suzhou, significantly streamlining the process [7] - Advanced technologies, including 5G and AI, are utilized to enhance security and operational efficiency, ensuring real-time monitoring and automated processes [7] Operational Achievements - The air freight station officially commenced operations on April 7, marking a significant milestone in logistics innovation within the region [8] - The introduction of unmanned delivery vehicles has further optimized logistics operations, allowing for seamless transportation between the free trade zone and the air freight station [9] Future Prospects - The success of the Suzhou air freight station is expected to serve as a model for other regions, with interest from neighboring areas looking to replicate this innovative logistics framework [10]

Group 1 - The company, SMIC (00981.HK), has appointed Professor Liu Ming as a member of the Board Nomination Committee [1] - Dr. Fan Rinda, an independent non-executive director, will no longer serve as a member of the Nomination Committee, effective from May 8, 2025 [1]

Group 1 - Dashi Intelligent signed a smart hospital project contract worth 58.12 million yuan with the First Affiliated Hospital of Bengbu Medical College and Bengbu Urban Construction Investment Development Co., Ltd. [1] - The project aims to create a comprehensive tumor specialty hospital integrating medical care, research, teaching, preventive health care, and rehabilitation, which is expected to positively impact the company's future performance [1] Group 2 - Huahong Company reported a net profit of 22.76 million yuan for Q1 2025, a year-on-year decrease of 89.73%, despite a revenue increase of 18.66% to 3.913 billion yuan [2] - The company specializes in the development and application of embedded/non-volatile memory, power devices, and other semiconductor technologies [2] Group 3 - Jindi Group announced a signed area of 214,000 square meters in April, a year-on-year decrease of 55.14%, with a signed amount of 2.78 billion yuan, down 55.45% [3] - The company focuses on real estate development and sales, commercial real estate, and property management [3] Group 4 - Jinlong Automobile reported a bus production of 4,361 units in April, a year-on-year decrease of 5.79%, with sales of 3,611 units, down 3.91% [4][5] - The company is engaged in the production and sales of bus products [5] Group 5 - Sanyou Medical established a joint venture with CGBio Co., Ltd. with a registered capital of 60 million yuan, focusing on innovative cell biological materials and regenerative medicine [6][7] - The company specializes in the research, production, and sales of orthopedic implant consumables [7] Group 6 - Jinzhi Technology won a bid for projects related to the State Grid with a total amount of 90.73 million yuan, accounting for 5.12% of the company's projected revenue for 2024 [9][10] - The company focuses on smart energy and smart city businesses [10] Group 7 - Pinggao Electric won multiple procurement projects from the State Grid, totaling approximately 1.751 billion yuan, which is 14.12% of the company's projected revenue for 2024 [10] - The company specializes in high-voltage switchgear and power engineering contracting [10] Group 8 - Luantang Pharmaceutical received approval for the raw material drug Celecoxib, which is a selective COX-2 inhibitor with fewer gastrointestinal side effects compared to traditional NSAIDs [11][12] - The company is involved in the research, production, and sales of pharmaceutical products [12] Group 9 - Dongjie Intelligent obtained seven patent certificates related to AGV and conveyor system technologies [13][14] - The company specializes in the research, design, manufacturing, installation, and debugging of intelligent logistics systems [14] Group 10 - XJH Holdings received a government subsidy of 8.69 million yuan, which accounts for 38.67% of the company's projected net profit for 2024 [15][16] - The company focuses on the recycling and dismantling of waste electrical products [16] Group 11 - Huaihua Pharmaceutical's subsidiary received approval for the clinical trial of HZ-J001 ointment for treating non-segmental vitiligo [17][19] - The company is engaged in the research, production, and sales of pharmaceutical products [19] Group 12 - ST Aonong reported a pig sales volume of 132,800 heads in April, a year-on-year decrease of 14.42%, while the stock of pigs increased by 15.06% [22][23] - The company is involved in feed, pig farming, food, and trade [23] Group 13 - Beibu Gulf Port reported a cargo throughput of 31.75 million tons in April, a year-on-year increase of 20.32% [24][25] - The company specializes in port loading, storage, and related services [25] Group 14 - Dongfang Iron Tower won a bid for State Grid projects totaling approximately 100 million yuan, which is 2.39% of the company's projected revenue for 2024 [26] - The company focuses on steel structures and related businesses [26] Group 15 - Huanxu Electronics reported a consolidated revenue of 4.641 billion yuan in April, a year-on-year increase of 0.72% [27] - The company provides design, manufacturing, and related services for brand customers [27] Group 16 - Jincheng Co. announced that part of its bank accounts has been frozen, involving approximately 32.97 million yuan due to contract disputes [28][29] - The company specializes in high-end intelligent equipment for photovoltaic and smart port sectors [29] Group 17 - NAIKE Equipment announced the departure of core technical personnel Wang Xiangguo [30][31] - The company focuses on semiconductor packaging equipment and related products [31] Group 18 - Jiaojian Co. won a construction project in Hefei with a bid amount of approximately 704 million yuan, covering residential buildings and related infrastructure [32][33] - The company specializes in infrastructure construction and related services [33] Group 19 - Hongyuan Green Energy plans to transfer a 27.07% stake in Inner Mongolia Xinyuan Silicon Material Technology Co., Ltd. for 1.245 billion yuan [34][35] - The company focuses on the research, production, and sales of aviation electromechanical products [35] Group 20 - Poly Development reported a signed amount of 24.622 billion yuan in April, a year-on-year decrease of 25.44% [46][48] - The company specializes in real estate development and sales [48]

Summary of the Conference Call for Jinghe Integrated Circuit Company Overview - **Company**: Jinghe Integrated Circuit - **Industry**: Semiconductor manufacturing, specifically focusing on integrated circuits (ICs) and related technologies Key Financial Metrics - **Q1 2025 Revenue**: 2.57 billion CNY, a year-on-year increase of approximately 15% [2][3] - **Net Profit**: Approximately 135 million CNY for Q1 2025, showing significant growth [2][3] - **Cash Flow**: Net cash inflow close to 600 million CNY in Q1 2025 [2][3] - **Gross Margin**: Increased to 27% in Q1 2025, with an expected range of 25%-27% for the full year [2][13] Capacity Expansion Plans - **Current Capacity**: Approximately 138,000 wafers, fully loaded [7] - **Planned Capacity for 2025**: Increase to between 165,000 and 170,000 wafers, with a focus on CIS and high-end 55nm products [2][7] - **Production Nodes**: 40nm products in mass production; 28nm products expected to begin small-scale production by the end of 2025 [2][8] Technology and Product Diversification - **Revenue Distribution by Application**: - DDIC: Decreased from 67% to 61% - CIS: Increased from 18% to 20% - PMIC: Increased from 9% to 11.5% - Logic and MCU: Approximately 7% [2][6] - **Future Product Focus**: Plans to increase CIS revenue share to around 25% and introduce more high-end products [19] Market and Pricing Outlook - **Consumer Electronics Market**: Recovery noted, but price increases are challenging; stability in pricing expected [10][11] - **Component Pricing**: No significant fluctuations anticipated in electronic component prices, including DDIC and MCU [11] - **North American Market**: Limited share; primarily focused on domestic demand [12] Research and Development - **R&D Expenses**: Expected to exceed 1.3 billion CNY in 2025, a year-on-year increase of about 10% [4][17] - **Depreciation**: Expected to approach 4 billion CNY due to ongoing expansions [17] Competitive Landscape - **Domestic Competition**: Increased pressure from local mature process wafer fabs; focus on technological advancement to maintain a competitive edge [18] - **International Collaboration**: Ongoing discussions with international terminal and IDM companies to expand market presence [16] Future Projections - **Long-term Capacity Goals**: Total capacity expected to reach 260,000 to 280,000 wafers within 3-5 years [19] - **Product Revenue Projections**: DDIC revenue share expected to decrease to 40%-45%, while absolute revenue increases; CIS expected to grow significantly [19] Additional Insights - **Airbi Product Development**: Anticipated market share of 8%-10% by 2026-2028, with strong growth in both domestic and international markets [20] - **CIS Client Development**: Key partnerships established, with significant production expected to meet demand [21] - **OLED Driver Market**: Detailed plans for market expansion and competition management [26] This summary encapsulates the key points from the conference call, highlighting the company's financial performance, strategic plans, market outlook, and competitive positioning within the semiconductor industry.

Financial Performance - The company reported a basic earnings per share of 0.0700 yuan for Q1 2025, a 75% increase compared to 0.0400 yuan in Q1 2024, and a significant improvement from -0.2200 yuan in Q1 2023 [1] - Net profit for Q1 2025 was 1.35 billion yuan, representing a 70.89% increase from 0.79 billion yuan in Q1 2024, and a recovery from a loss of 3.31 billion yuan in Q1 2023 [1] - Operating revenue reached 25.68 billion yuan in Q1 2025, up 15.26% from 22.28 billion yuan in Q1 2024, and a substantial increase from 10.9 billion yuan in Q1 2023 [1] - The return on equity (ROE) improved to 0.65% in Q1 2025, an 80.56% increase from 0.36% in Q1 2024, and a recovery from -2.55% in Q1 2023 [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 61,456.66 million shares, accounting for 52.23% of the circulating shares, with a decrease of 899.35 million shares compared to the previous period [1] - The largest shareholder, Lichin Innovation Investment Holdings Co., Ltd., holds 38,273.22 million shares, representing 32.53% of the total share capital, with no change in holdings [2] - Midea Innovation Investment Co., Ltd. reduced its holdings by 1,173.70 million shares, now holding 5,102.21 million shares, which is 4.34% of the total share capital [2] Dividend Policy - The company has announced that it will not distribute dividends or transfer shares this time [3]

公司代码：688981 公司简称：中芯国际 中芯国际集成电路制造有限公司全体股东： 根据《企业内部控制基本规范》及其配套指引的规定和其他内部控制监管要求（以下简称企业内部控制 规范体系），结合本公司（以下简称公司）内部控制制度和评价办法，在内部控制日常监督和专项监督 的基础上，我们对公司2024年12月31日（内部控制评价报告基准日）的内部控制有效性进行了评价。 一. 重要声明 按照企业内部控制规范体系的规定，建立健全和有效实施内部控制，评价其有效性，并如实披露内部控 制评价报告是公司董事会的责任。经理层负责组织领导企业内部控制的日常运行。公司董事会及董事、 高级管理人员保证本报告内容不存在任何虚假记载、误导性陈述或重大遗漏，并对报告内容的真实性、 准确性和完整性承担个别及连带法律责任。 公司内部控制的目标是合理保证经营管理合法合规、资产安全、财务报告及相关信息真实完整，提高经 营效率和效果，促进实现发展战略。由于内部控制存在的固有局限性，故仅能为实现上述目标提供合理 保证。此外，由于情况的变化可能导致内部控制变得不恰当，或对控制政策和程序遵循的程度降低，根 据内部控制评价结果推测未来内部控制的有效性具有一定 ...

星标 ★ IPO日报 精彩文章第一时间推送 本周（4月21日至4月25日），据证监会官网新增披露，西安新通药物研究股份有限公司（下称"新通药物"）、深圳市千分一智能技术股份有限公司 （下称"千分一"）、浙江亘古电缆股份有限公司（下称"亘古电缆"）、北京煜鼎增材制造研究院股份有限公司（下称"煜鼎增材"）、粤芯半导体技术 股份有限公司（下称"粤芯半导体"）等5家公司进行了上市辅导备案。 截至4月25日， 4月披露进行上市辅导备案的公司有18家。2025年以来，IPO辅导备案新增110家。 IPO日报注意到，新通药物是注册制以来，科创板首例未能在批文有效期内启动发行从而IPO失败的公司； 千分一占据主动笔全球25%市场份额；技术大 佬云集的煜鼎增材辅导前完成由雄安新区政府平台领投的B轮融资；广东本土半导体企业粤芯半导体集齐广汽资本、上汽投资、北汽投资参股，融资金额 超过55亿元。 制图：佘诗婕 拿到批文却没上市 具体来看，新通药物成立于2000年，注册资本约3.7亿元，聚焦于慢性乙肝、肝癌、癫痫等重大疾病领域药物研发。 新通药物于4月21日向陕西证监局递交了IPO辅导备案，辅导机构为中信证券。 这不是新通药物第一次 ...